First-of-its-kind study reveals a new culprit in the formation of brain hemorrhages

A first-of-its-kind study led by the University of California, Irvine has revealed a new culprit in the formation of brain hemorrhages that does not involve injury to the blood vessels, as previously believed.

Hyperbaric Oxygen Therapy Shows Some Benefit After Breast Cancer Irradiation

Hyperbaric oxygen therapy (HBOT) was not effective for reducing pain, but was effective for reducing fibrosis, among women with late local toxic effects after irradiation

February 9, 2024

Most cancers have no screening test. Let’s change that

Toni Roberts was 58 when she began to experience gastrointestinal issues. She modified her diet and tried over-the-counter remedies, but her symptoms did not improve.

January 8, 2025

Risk Adjusted Net Present Value: What is the current valuation of Fusion Pharmaceuticals’s FPI-1434

The revenue for FPI-1434 is expected to reach an annual total of $65 mn by 2039 in the US based off GlobalData’s Expiry Model. The

July 31, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.